Mutual of America Capital Management LLC Purchases 15,725 Shares of OrthoPediatrics Corp. $KIDS

Mutual of America Capital Management LLC raised its position in shares of OrthoPediatrics Corp. (NASDAQ:KIDS) by 9.3% in the second quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 185,033 shares of the company’s stock after purchasing an additional 15,725 shares during the quarter. Mutual of America Capital Management LLC owned 0.76% of OrthoPediatrics worth $3,975,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Brown Advisory Inc. boosted its position in shares of OrthoPediatrics by 6.2% during the first quarter. Brown Advisory Inc. now owns 1,628,747 shares of the company’s stock valued at $40,116,000 after buying an additional 94,719 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of OrthoPediatrics by 1.5% during the 1st quarter. Vanguard Group Inc. now owns 937,969 shares of the company’s stock valued at $23,102,000 after acquiring an additional 14,079 shares during the last quarter. Millennium Management LLC boosted its holdings in shares of OrthoPediatrics by 55.3% during the 1st quarter. Millennium Management LLC now owns 656,578 shares of the company’s stock valued at $16,172,000 after acquiring an additional 233,873 shares during the last quarter. AWM Investment Company Inc. boosted its holdings in shares of OrthoPediatrics by 5.5% during the 1st quarter. AWM Investment Company Inc. now owns 545,282 shares of the company’s stock valued at $13,430,000 after acquiring an additional 28,488 shares during the last quarter. Finally, Harbor Capital Advisors Inc. boosted its holdings in shares of OrthoPediatrics by 116.5% during the 2nd quarter. Harbor Capital Advisors Inc. now owns 333,959 shares of the company’s stock valued at $7,173,000 after acquiring an additional 179,733 shares during the last quarter. Hedge funds and other institutional investors own 69.05% of the company’s stock.

OrthoPediatrics Stock Down 0.2%

Shares of KIDS opened at $17.88 on Thursday. The stock has a market capitalization of $448.25 million, a price-to-earnings ratio of -9.99 and a beta of 1.02. The business’s 50 day simple moving average is $19.22 and its 200-day simple moving average is $20.67. The company has a debt-to-equity ratio of 0.27, a current ratio of 6.66 and a quick ratio of 3.43. OrthoPediatrics Corp. has a 1 year low of $15.28 and a 1 year high of $32.00.

OrthoPediatrics (NASDAQ:KIDS) last announced its earnings results on Monday, January 9th. The company reported ($0.15) earnings per share for the quarter. OrthoPediatrics had a negative net margin of 18.92% and a negative return on equity of 6.36%. The firm had revenue of $25.08 million during the quarter. As a group, equities analysts expect that OrthoPediatrics Corp. will post -0.93 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CFO Fred Hite acquired 5,076 shares of the firm’s stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $19.41 per share, for a total transaction of $98,525.16. Following the acquisition, the chief financial officer directly owned 213,065 shares of the company’s stock, valued at $4,135,591.65. This represents a 2.44% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at this hyperlink. 32.70% of the stock is owned by insiders.

Analyst Ratings Changes

Several research analysts have issued reports on the company. Truist Financial set a $18.00 target price on OrthoPediatrics in a research report on Friday, October 10th. Weiss Ratings reissued a “sell (e+)” rating on shares of OrthoPediatrics in a report on Wednesday, October 8th. JMP Securities dropped their price objective on shares of OrthoPediatrics from $35.00 to $25.00 and set a “market outperform” rating on the stock in a report on Friday, October 10th. Citigroup reissued an “outperform” rating on shares of OrthoPediatrics in a report on Friday, October 10th. Finally, Stifel Nicolaus dropped their price target on shares of OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Seven equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $26.29.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products.